MRI has several advantages relative to other imaging modalities in evaluating, diagnosing, and planning treatment for prostate cancer. However, it is rarely ordered for localized disease. While the ...
Polo-like kinase-1 as a potential prognostic marker of prostate cancer utilizing ORIEN data. This is an ASCO Meeting Abstract from the 2023 ASCO Genitourinary Cancers Symposium. This abstract does not ...
The impact of pelvic radiotherapy on hematological outcomes in pediatric genitourinary rhabdomyosarcoma. This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers Symposium. This ...
FORT MYERS, Fla., Jan. 30, 2025 /PRNewswire/ -- Clinical research conducted at Florida Cancer Specialists & Research Institute, LLC (FCS) is expanding treatment options and contributing to improved ...